The United States of America, As Represented by the Secretary, Department of Health and Human Services

Ana P Cotrim

James B Mitchell

J Silvio Gutkind

Vyomesh Patel

Alfredo Molinolo

Ramiro Iglesias-Bartolome

Disclosed is a method of preventing the development of mucositis in a subject undergoing radiation therapy or chemotherapy for a disease in need thereof comprising administering an effective amount of a mammalian target of rapamycin (mTOR) inhibitor, such as rapamycin, to the subject. Further disclosed is a method of increasing the lifespan of a normal oral keratinocyte and/or reducing oxidative stress in a normal epithelial cell, wherein the method comprises administering an effective amount of an mTOR inhibitor to a subject undergoing radiation therapy or chemotherapy for a disease in need thereof.

Growing community of inventors

Bethesda, MD, United States of America

Ana P Cotrim